Workflow
Longevity - based investing
icon
Search documents
Abacus Life(ABL) - 2025 Q3 - Earnings Call Transcript
2025-11-06 23:00
Financial Data and Key Metrics Changes - Total revenue increased 124% year-over-year to $63 million, compared to $28.1 million in the prior year [4][20] - Adjusted net income rose 60% to $23.6 million, while adjusted EBITDA increased 127% to $37.9 million [4][23] - The company raised its 2025 guidance to a range of $80-$84 million, representing year-over-year growth of 72%-81% [4][24] Business Line Data and Key Metrics Changes - The Life Solutions segment benefited from a highly efficient origination platform and active trading division, contributing significantly to revenue growth [20] - The asset management segment generated $8.6 million in revenue during Q3, with $102 million of new inflows, demonstrating the value of strategic M&A activity [20] Market Data and Key Metrics Changes - Year-to-date, the company raised $468 million across all fund strategies, with Q3 inflows representing $102 million [9] - The average publicly traded alternative asset manager trades at roughly 20 times projected 2025 earnings, while the company trades in the mid-single digits, indicating a significant valuation disconnect [8] Company Strategy and Development Direction - The company initiated an annual dividend of $0.20 per share and a $10 million share repurchase program, reflecting confidence in its long-term strategy [4][5] - The acquisition of AccuQuote is expected to enhance competitive position and broaden origination and global wealth platforms [10][11] Management's Comments on Operating Environment and Future Outlook - Management emphasized the structural differentiation of longevity-based assets, which are uncorrelated to traditional markets, providing consistent exposure [11][12] - The company aims to increase recurring fee-based revenue, which commands higher valuations, and is committed to clear communication with investors [9][10] Other Important Information - The company achieved a major milestone with a $50 million above investment-grade securitization product note backed by life insurance assets, validating strong institutional demand [12][15] - The annualized adjusted return on equity was 22%, and the annualized adjusted return on invested capital was 21% for the quarter [23] Q&A Session Summary Question: Inquiry about securitization and additional economics - Management confirmed that they will retain servicing fees on the securitized assets, which will produce additional fee-related earnings [30] Question: Update on advertising efforts and KPIs - Management noted a 10% increase in Q3 revenue compared to the previous year, attributing success to increased advertising efforts [32] Question: Capital deployed and expectations for future capital deployment - Management indicated that $120 million is a reasonable run rate for future capital deployment, driven by increased demand from institutional investors [39] Question: Thoughts on the new dividend and capital allocation - Management explained that the dividend is a way to capitalize shareholders while still pursuing growth opportunities, with a conservative payout ratio [44][46] Question: Unit economics and revenue from securitization - Management stated that the unit economics from securitization are compelling and will provide consistency in profitability and margins over time [51][54] Question: Progress on Abacus Wealth Advisors and AUM goals - Management expressed confidence in the growth of the wealth advisory segment and highlighted the importance of being selective in acquisitions [56] Question: Realized gains and holding periods for policies - Management explained that longer holding periods for policies led to increased realized gains, and they aim to maintain a target of north of 20% for future gains [60][63]